Cite
Rensi N, Sammarco A, Moccia V, et al. Evaluation of TFR-1 Expression in Feline Mammary Cancer and In Vitro Antitumor Efficacy Study of Doxorubicin-Loaded H-Ferritin Nanocages. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061248.
Rensi, N., Sammarco, A., Moccia, V., Calore, A., Torrigiani, F., Prosperi, D., Rizzuto, M. A., Bellini, M., De Maria, R., Bonsembiante, F., Ferro, S., Zanetti, R., Zappulli, V., & Cavicchioli, L. (2021). Evaluation of TFR-1 Expression in Feline Mammary Cancer and In Vitro Antitumor Efficacy Study of Doxorubicin-Loaded H-Ferritin Nanocages. Cancers, 13(6), . https://doi.org/10.3390/cancers13061248
Rensi, Nicolò, et al. "Evaluation of TFR-1 Expression in Feline Mammary Cancer and In Vitro Antitumor Efficacy Study of Doxorubicin-Loaded H-Ferritin Nanocages." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061248
Rensi N, Sammarco A, Moccia V, Calore A, Torrigiani F, Prosperi D, Rizzuto MA, Bellini M, De Maria R, Bonsembiante F, Ferro S, Zanetti R, Zappulli V, Cavicchioli L. Evaluation of TFR-1 Expression in Feline Mammary Cancer and In Vitro Antitumor Efficacy Study of Doxorubicin-Loaded H-Ferritin Nanocages. Cancers (Basel). 2021 Mar 12;13(6). doi: 10.3390/cancers13061248. PMID: 33809013; PMCID: PMC8000254.
Copy
Download .nbib